1Delbe ke D,Martin WH. PE and PET- CT for evaluation of colorectal carcinoma[J]. Semin Nuel Med, 2004, 34(3) : 209 - 223.
2Esteves FP, Schuster DM, Halkar RK, et al. Gastrointestinal tractmalignancies and positron emission tomography: an overview[J]. Semin Nucl Med, 2006, 36(2):169 - 181.
3Bloomston M, Bekaii Saab TS, Kosuri K, et al. Preoperative carbohydrate antigen is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection[J]. Pancreas,2006,33(3) :246 - 249.
4Lee IK, Kimdo H, Gorden DL, et al. Prognostic value of CEA and CA19 - 9 tumor markers combined with cytology from peritoneal fluid in coiorectal cancer [J]. Ann Surg Oncol, 2009,16(4):861 - 870.
5Chen CC,Yang SH,Lin JK,et al. Is it reasonable to add preoperative serum level of CEA and CA19 - 9 to staging for colorectal cancer[J]. J Surg Res, 2005,124(2) : 169 - 174.
6Morita S, Nomura T, Fukushima Y, et al. Does serum CA19 - 9 play a practical role in the management of patients with colorectal cancer[J]. Dis Colon Rectum, 2010,47 (2): 227 - 232.
7Kanellos I,Zacharakis E,Kanellos D,et al. Prognostic significance of CEA levels and detection of CEA mRNA in draining venous blood in patients with colorectal cancer[J]. J Surg Oncol,2009,94(1):3 - 8.
8Meyerhardt JA,Mayer RJ. Follow - up strategies after curative resection of colorectal cance[J]. Semin Oneol, 2008, 30 (3):349 - 360.
9Polyak K, Lee MH, Bromage HE, et al. Cloning of a cylin- dependent Kinase inhibitor and a potential mediator[J]. Cell, 1994,78:59 - 66.
10Loda J, Bhattacharya N, Ong YC, et al. Decreased levels of the cell- cycle inhibitor P27 KIP1 protein: progenostic implietion in primary breast cancer[J]. Natl Med,2009,3 :227- 230.
